21 July 2020 : Original article
Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
Jae Hun Chung1ACDEF, Je Ho Ryu123A*, Kwang Ho Yang12A, Byung Hyun Choi12CD, Youngmok Park45AB, Tae Beom Lee12BF, Jae Ryong Shim12C, Hyo Jung Ko12F, Sung Hwan Cho16DEDOI: 10.12659/AOT.923211
Ann Transplant 2020; 25:e923211
Table 1 Clinical characteristics of conventional group and reduction group.
Conventional group (n=102) | Weight reduction group (n=7) | p-Value | |
---|---|---|---|
Sex | M=76/F=26 | M=7 | 0.126 |
Age | 27.99±9.31 | 32.14±7.31 | 0.251 |
BW (kg) | 65.77±11.27 | 85.4±8.25 | 0.052 |
BMI (BMI, kg/m) | 23.13±3.27 | 28.89±2.30 | 0.025 |
Steatsosis (%) | 6.19±5.68 | 40.71±14.56 | <0.001 |
Relation | |||
Related | 95 | 5 | 0.466 |
Non-related | 7 | 2 | |
Sex | M=78/F=24 | M=4/F=3 | 0.252 |
Age | 51.39±9.94 | 53.86±5.15 | 0.142 |
CTP | 1.66±0.84 | 1.71±0.95 | 0.862 |
MELD | 12.71±7.56 | 8.43±4.47 | 0.518 |
Etiology | |||
HCC | 69 | 6 | 0.989 |
Alcoholic LC | 10 | – | |
Viral LC (B or C) | 16 | 1 | |
Others | 7 | – | |
BW – body weight; BMI – body mass index; MELD – Model For End-Stage Liver Disease. CTP – Child-Turcotte-Pugh; HCC – hepatocellular carcinoma; LC – liver cirrhosis. |